128 related articles for article (PubMed ID: 10851091)
41. E2F1-mediated upregulation of p19INK4d determines its periodic expression during cell cycle and regulates cellular proliferation.
Carcagno AL; Marazita MC; Ogara MF; Ceruti JM; Sonzogni SV; Scassa ME; Giono LE; Cánepa ET
PLoS One; 2011; 6(7):e21938. PubMed ID: 21765927
[TBL] [Abstract][Full Text] [Related]
42. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
Guan KL; Jenkins CW; Li Y; O'Keefe CL; Noh S; Wu X; Zariwala M; Matera AG; Xiong Y
Mol Biol Cell; 1996 Jan; 7(1):57-70. PubMed ID: 8741839
[TBL] [Abstract][Full Text] [Related]
43. Features of macrophage differentiation induced by p19INK4d, a specific inhibitor of cyclin D-dependent kinases.
Adachi M; Roussel MF; Havenith K; Sherr CJ
Blood; 1997 Jul; 90(1):126-37. PubMed ID: 9207446
[TBL] [Abstract][Full Text] [Related]
44. The INK4 family of CDK inhibitors.
Carnero A; Hannon GJ
Curr Top Microbiol Immunol; 1998; 227():43-55. PubMed ID: 9479825
[No Abstract] [Full Text] [Related]
45. Regulation of the ubiquitin proteasome pathway in human lens epithelial cells during the cell cycle.
Liu Q; Shang F; Guo W; Hobbs M; Valverde P; Reddy V; Taylor A
Exp Eye Res; 2004 Feb; 78(2):197-205. PubMed ID: 14729352
[TBL] [Abstract][Full Text] [Related]
46. The cyclin-dependent kinase inhibitors p18INK4c and p19INK4d are highly expressed in CD34+ progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells.
Tschan MP; Peters UR; Cajot JF; Betticher DC; Fey MF; Tobler A
Br J Haematol; 1999 Sep; 106(3):644-51. PubMed ID: 10468852
[TBL] [Abstract][Full Text] [Related]
47. [The ubiquitin-ligating system: from the discovery to the present].
Tanaka K
Tanpakushitsu Kakusan Koso; 1999 May; 44(6):737-43. PubMed ID: 10341545
[No Abstract] [Full Text] [Related]
48. Monoclonal antibody probes for p21WAF1/CIP1 and the INK4 family of cyclin-dependent kinase inhibitors.
Thullberg M; Welcker M; Bartkova J; Kjerulff AA; Lukas J; Högberg J; Bartek J
Hybridoma; 2000 Feb; 19(1):63-72. PubMed ID: 10768842
[TBL] [Abstract][Full Text] [Related]
49. Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme.
Lam PY; Di Tomaso E; Ng HK; Pang JC; Roussel MF; Hjelm NM
Br J Neurosurg; 2000 Feb; 14(1):28-32. PubMed ID: 10884881
[TBL] [Abstract][Full Text] [Related]
50. Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway.
Honda K; Mihara H; Kato Y; Yamaguchi A; Tanaka H; Yasuda H; Furukawa K; Urano T
Oncogene; 2000 Jun; 19(24):2812-9. PubMed ID: 10851084
[TBL] [Abstract][Full Text] [Related]
51. NMR structural characterization of the CDK inhibitor p19INK4d.
Kalus W; Baumgartner R; Renner C; Noegel A; Chan FK; Winoto A; Holak TA
FEBS Lett; 1997 Jan; 401(2-3):127-32. PubMed ID: 9013872
[TBL] [Abstract][Full Text] [Related]
52. C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest.
Wang H; Goode T; Iakova P; Albrecht JH; Timchenko NA
EMBO J; 2002 Mar; 21(5):930-41. PubMed ID: 11867521
[TBL] [Abstract][Full Text] [Related]
53. p19INK4d: More than Just a Cyclin-Dependent Kinase Inhibitor.
Han X; Kuang Y; Chen H; Liu T; Zhang J; Liu J
Curr Drug Targets; 2020; 21(1):96-102. PubMed ID: 31400265
[TBL] [Abstract][Full Text] [Related]
54. p19INK4d is involved in the cellular senescence mechanism contributing to heterochromatin formation.
Sonzogni SV; Ogara MF; Belluscio LM; Castillo DS; Scassa ME; Cánepa ET
Biochim Biophys Acta; 2014 Jul; 1840(7):2171-83. PubMed ID: 24667034
[TBL] [Abstract][Full Text] [Related]
55. Conformational switch upon phosphorylation: human CDK inhibitor p19INK4d between the native and partially folded state.
Löw C; Homeyer N; Weininger U; Sticht H; Balbach J
ACS Chem Biol; 2009 Jan; 4(1):53-63. PubMed ID: 19063602
[TBL] [Abstract][Full Text] [Related]
56. Activation of the cyclin-dependent kinase CTDK-I requires the heterodimerization of two unstable subunits.
Hautbergue G; Goguel V
J Biol Chem; 2001 Mar; 276(11):8005-13. PubMed ID: 11118453
[TBL] [Abstract][Full Text] [Related]
57. [Regulation of cell division by ubiquitin-dependent proteolysis and spindle assembly checkpoint].
Kazuo T
Tanpakushitsu Kakusan Koso; 1999 Mar; 44(3):253-62. PubMed ID: 10097657
[No Abstract] [Full Text] [Related]
58. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
McShea A; Harris PL; Webster KR; Wahl AF; Smith MA
Am J Pathol; 1997 Jun; 150(6):1933-9. PubMed ID: 9176387
[TBL] [Abstract][Full Text] [Related]
59. p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index.
Bouvier-Labit C; Civatte M; Bartoli C; Renaud W; Pellissier JF; Figarella-Branger D
Neuropathol Appl Neurobiol; 1999 Oct; 25(5):408-16. PubMed ID: 10564531
[TBL] [Abstract][Full Text] [Related]
60. Gadzooks!
MacDonald ME
Nat Genet; 1999 Sep; 23(1):10-1. PubMed ID: 10471487
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
